Access cutting-edge alopecia areata treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access alopecia areata specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alopecia areata treatment provided free
Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the body. The purpose of this study is to assess how safe, effective, and tolerable upadacitinib is in adolescent and adult participants with severe AA. Upadacitinib is an approved drug being investigated for the treatment of AA. In Study 1 and Study 2 and Study 4 Period A, participants are placed in 1 of
Sponsor: AbbVie
Check if you qualify for this alopecia areata clinical trial in Los Angeles, CA
If you're searching for alopecia areata treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alopecia areata specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.